Efficacy of Olanzapine-Triple Antiemetic Regimen in Patients with Gastrointestinal Tumor and High Risk of Chemotherapy-Induced Nausea and Vomiting Receiving Moderately Emetogenic Chemotherapy: A Retrospective Study

PURPOSE: Dexamethasone combined with 5-hydroxytryptamine type 3 receptor antagonists (5-HT3 RA) dual regimen is the standard prophylaxis regimen for patients receiving moderately emetogenic chemotherapy (MEC). However, it has been found in real-world practice that chemotherapy-induced nausea and vom...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Manag Res
Hoofdauteurs: Wu, Xuan, Wu, Jingxun, Tong, Gangling, Cheng, Boran, Chen, Minhua, Yu, Shaokang, He, Lirui, Li, Zhu, Wang, Shubin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove 2020
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7402666/
https://ncbi.nlm.nih.gov/pubmed/32801895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S254398
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items